Medical Advisor Clinical trials
Pubblicato il 19-08-2026 - Astrazeneca in Italia
Are you ready to shape the scientific narrative in amyloidosis and turn robust evidence into actions that change patient outcomes? You will anchor the medical strategy, lead cross-functional initiatives, and ensure every engagement is scientifically rigorous and fully compliant.Can you see yourself building trusted partnerships with leading clinicians while guiding studies and education that raise the standard of care? Operating at the intersection of medical affairs, clinical research, and commercial collaboration, you will lead initiatives that strengthen our presence with specialists. With access to globalexpertiseand the agility to move at pace, you will translate complex biology into meaningful impact for people who need it most.Medical plan and project leadership:Own delivery of the medical plan and lead local clinical, observational, and diagnostic screening projects with cross-functional partners—on time, on budget, and with measurable impact.Build and continuously deepenexpertisein amyloidosis and our therapies;monitorliterature and data,
then translate learnings into clear guidance, actions, and field enablement.Uphold local laws, codes, and internal policies across all materials, activities, and educational programs to ensure ethical, compliant operations.Medical education and materials:Create high-quality educational content and provide scientific support for the development, review, and approval of materials for scientific meetings, symposia, and other medical education activities.Scientific exchange:Deliver reactive, on-site scientific presentations;participatein local meetings to educate, gather intelligence, and bring back insights that shape strategy.Pharmacovigilance collaboration:Partner with safety teams to address medical issues related to adverse events, supporting patient safety and effective risk communication.Commercial partnership:Work with marketing and sales to craft scientifically sound promotional messages, supportive documentation, and